Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,633.28
(
-1.23%
)
US TECH 100
23,852.80
(
-1.16%
)
Dow Jones
46,242.69
(
-1.60%
)
Brent Oil
105.85
(
5.17%
)
Bitcoin
71,136.77
(
-3.79%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 161558

Thursday, 05/23/2013 1:34:06 PM

Thursday, May 23, 2013 1:34:06 PM

Post# of 257253
Hey, I didn't check twitter, but your tweet is at the bottom of the article. What a load of misleading statements and graphs from JNJ. Xtandi hasn't approved in chemo naive CRPC yet, Zytiga has lost market share in chemo treated since Xtandi's approval, but they stated Zytiga increased market share overall since Zytiga's approval in chemo naive.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now